0001415889-21-005123.txt : 20211109
0001415889-21-005123.hdr.sgml : 20211109
20211109213016
ACCESSION NUMBER: 0001415889-21-005123
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211108
FILED AS OF DATE: 20211109
DATE AS OF CHANGE: 20211109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENMAN HERM
CENTRAL INDEX KEY: 0001230057
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211394136
MAIL ADDRESS:
STREET 1: OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE, HILTON PARK
CITY: SAN DIEGO
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4/A
1
form4a-11092021_061106.xml
X0306
4/A
2021-11-08
2021-11-09
0001604821
Natera, Inc.
NTRA
0001230057
ROSENMAN HERM
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
false
Common Stock
2021-11-08
4
M
0
44503
2.6569
A
95778
D
Common Stock
2021-11-08
4
S
0
39171
117.1273
D
56607
D
Common Stock
2021-11-08
4
S
0
2100
118.7880
D
54507
D
Common Stock
2021-11-08
4
S
0
2832
119.6180
D
51675
D
Common Stock
2021-11-08
4
S
0
400
120.2400
D
51275
D
Stock Option (right to buy)
2.6569
2021-11-08
4
M
0
44503
0
D
2024-02-24
Common Stock
44503
93901
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.00 to $117.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The prior Form 4 report filed on November 9, 2021 inaccurately reflected $17.1273 as the weighted average sales price instead of $117.1273.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.12 to $119.0250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.16 to $120.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.19 to $120.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares are fully vested and may be exercised at any time.
/s/ Tami Chen, Attorney-in-Fact
2021-11-09